Foxx Development Backs Out of San Diego Smartphone Factory Plans

2026-16104, Foreign-Trade Zone (FTZ) 21, Notification of Proposed Production Activity; Translucent Solar, LLC; (Solar Modules); Summerville, South Carolina

Translucent Solar, LLC wants to make solar panels in Summerville, South Carolina, using some imported parts with special duty rules inside Foreign-Trade Zone 21. This move could save money on import taxes and speed up production. Public comments are open until September 16, 2026, so folks can share their thoughts before the plan moves forward.

2026-15937, Foreign-Trade Zone (FTZ) 18, Notification of Proposed Production Activity; Western Digital Technologies, Inc.; (Semiconductor Die); San Jose and Fremont California

2026-15804, Foreign-Trade Zone (FTZ) 12; Authorization of Production Activity; Avant Technology, Inc.; (Solid-State Drives and Memory Modules); Pharr, Texas

2026-15564, Foreign-Trade Zone (FTZ) 202, Notification of Proposed Production Activity; Industrial Parts Depot, LLC; (Engine Parts and Components); Carson, California

2026-15422, Foreign-Trade Zone (FTZ) 153, Notification of Proposed Production Activity; Aptera Motors Corp; (Solar Electric Vehicles); Carlsbad, California

Aptera Motors in Carlsbad, California wants to make solar electric vehicles using some imported parts with special trade benefits. This means they can save on import taxes (ranging from 0% to 5.5%) for parts like batteries, airbags, and body panels. The plan was officially submitted on July 23, 2026, and if approved, it could help Aptera build greener cars more affordably and faster.

2026-14967, Foreign-Trade Zone (FTZ) 45; Authorization of Limited Production Activity; SSI Shredding Systems, Inc.; (Industrial Shredders and Compactors); Wilsonville and Portland, Oregon

SSI Shredding Systems in Oregon got the green light to start limited production of industrial shredders and compactors in their Foreign-Trade Zone facilities. They must pay duties on steel and aluminum parts unless special trade rules apply. This change kicks in now and helps SSI grow while following trade rules.

Previous: 2026-16353, Reauthorization of the Generic Drug User Fee Amendments; Public Meeting; Request for Comments

The Food and Drug Administration (FDA, the Agency, or we) is hosting a public meeting to discuss proposed recommendations for the reauthorization of the Generic Drug User Fee Amendments (GDUFA) for fiscal years (FYs) 2028 to 2032. GDUFA amended the Federal Food, Drug, and Cosmetic Act (FD&C Act) to authorize FDA to assess and collect fees to support human generic drug activities. The current legislative authority for GDUFA expires at the end of September 2027. At that time, new legislation will be required for FDA to continue to assess and collect generic drug user fees for future fiscal years. The FD&C Act directs FDA, following negotiations with the regulated industry and periodic consultations with other stakeholders, to present recommendations for reauthorization of the GDUFA program to the relevant Congressional committees, publish the recommendations in the Federal Register, provide for a period of 30 days for the public to provide written comments on such recommendations, and hold a meeting at which the public may present its views on such recommendations. FDA will then consider such public views and comments and revise such recommendations as necessary.

Next: 2026-16356, Foreign-Trade Zone (FTZ) 61, Notification of Proposed Production Activity; Viatris Pharmaceuticals LLC; (Medications); Vega Baja, Puerto Rico